Prostate cancer (PCa)External beam radiation therapy (EBRT)Brachytherapy (BT)Toxicity complicationsLower urinary tract symptoms (LUTS)Use of radiotherapy including external beam radiation therapy ( EBRT ), brachytherapy (BT), and combination therapy ( EBRT +BT) for the treatment of prostate cancer (...
Approximately 90% of men experience anejaculation after radiation therapy for prostate cancer; onset can be delayed, with the number of men experiencing it increasing over time.
PURPOSE: To analyze the frequency and clinical importance of proctitis and hematochezia after radiation therapy for prostate cancer. MATERIALS AND METHODS: Of 63 patients with prostate cancer treated with curative intent by a single radiation oncologist between July 1, 1993, and December 31, 1997, ...
In 5 to 10 percent of patients who receive radiation therapy for prostate cancer, there is a side effect that can show up months to years later -- hemorrhagic cystitis. Why does this problem occur in the bladder after radiation treatment to kill cancer cells in the prostate? "The bladder i...
Surrogate End Point for Prostate Cancer-Specific Mortality After Radical Prostatectomy or Radiation Therapy. Journal of the National Cancer Institute. 2003; 95... Amico,Anthony,D V.,... - 《Jnci Journal of the National Cancer Institute》 被引量: 447发表: 2003年 Surrogate End Point for Prostate...
More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a biochemical recurrence after radical prostatectomy. Clinical guidelines for the management of these patients largely focus on the use of salvage radiotherapy with or without systemic therapy. However, not all ...
The role of external beam radiation therapy after prostatectomy for prostate cancer. Cancer 1986;58: 2406-10.Hanks GE, and Dawson AK: The role of external beam radiation therapy after prostatectomy for prostate cancer. Cancer 58: 2406 -2410, 1986....
Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer Surgery is the therapy of choice for patients with local renal cancer, but the results are unsatisfactory if the disease is locally advanced or systemic di... Michel,Bolla,Jean-Luc...
Muscle-invasive bladder cancer (MIBC) is an aggressive disease for which the gold-standard treatment is radical cystectomy (RC) in combination with cisplatin-based neoadjuvant chemotherapy. Bladder-sparing strategies such as trimodal therapy (TMT) have also emerged to improve health-related quality of...
QUALITY OF LIFE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER: DIFFERENCES BASED ON TREATMENT MODALITY We compared general and disease specific health related quality of life after 103Pd treatment, radical prostatectomy and external beam radiation therapy given ... JOHN,W.,DAVIS,... - 《Journal of...